CTT PHARMACEUTICAL HOLDINGS, INC.
Datakwaliteit: 83%
CTTH
OTC
Energy
Metal Mining
€ 0,07
€ 0,00
(0,00%)
Marktkapitalisatie: 3,82 M
Prijs
€ 0,07
Marktkapitalisatie
3,82 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Earnings grew 106,26% over the past year
Negative free cash flow of -131.174,0
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)106,26%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-89,30%
Onder sectorgemiddelde (3,74%)
ROIC-72,02%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A
Waardering
PE (TTM)
-4,97
Onder sectorgemiddelde (3,38)
P/B Ratio5,18
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Energy sector mediaan (547 peers)
Sectorvergelijking
vs Energy sector mediaan (547 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -5,0 | 3,4 |
| P/B | 5,2 | 2,1 |
| ROE % | -89,3 | 3,7 |
| Net Margin % | — | 4,9 |
| Rev Growth 5Y % | — | 9,4 |
| D/E | — | 0,5 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
Geen toekomstige schattingen beschikbaar
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | 106,26% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -770.159,0 |
| ROE | -89,30% | ROA | -73,16% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -131.174,0 |
| ROIC | -72,02% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | 738.078 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4,97 | Forward P/E | N/A |
| P/B Ratio | 5,18 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -3,43% | ||
| Market Cap | 3,82 M | Enterprise Value | 3,79 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 17,03% |
| SBC-Adj. FCF | -270.398 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Net Income | 227.838,0 | 110.464,0 | -1,00 M | 3,74 M |
| EPS (Diluted) | — | 0,01 | -0,11 | 0,40 |
| Gross Profit | — | — | — | — |
| Operating Income | -672.162,0 | 92.201,0 | -1,19 M | -757.935,0 |
| EBITDA | — | — | — | — |
| R&D Expenses | — | — | — | — |
| SG&A Expenses | — | — | — | — |
| D&A | — | — | — | 0,0 |
| Interest Expense | — | — | — | — |
| Income Tax | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|
| Total Assets | 1,66 M | 6.252,0 | 203.079,0 | 4,18 M |
| Total Liabilities | 1,08 M | 249.378,0 | 589.413,0 | 3,73 M |
| Shareholders' Equity | 586.630,0 | -243.126,0 | -386.334,0 | 456.450,0 |
| Total Debt | — | — | — | — |
| Cash & Equivalents | 81.179,0 | 823,0 | 12.091,0 | 569.378,0 |
| Current Assets | 1,05 M | 6.252,0 | 203.079,0 | 750.734,0 |
| Current Liabilities | — | 249.378,0 | 589.413,0 | 3,73 M |
{"event":"ticker_viewed","properties":{"ticker":"CTTH","listing_kind":"stock","pathname":"/stocks/ctth","exchange":"OTC","country":"US"}}